17 AprilAnalyst Stuart RobertsAssociate Analyst Tanushree Jain

First Page		Document Content
Date: 2014-02-16 20:47:19 Protease inhibitors Health HIV/AIDS Virology Hepatitis Peginterferon alfa-2a MiR-122 Hepatitis C virus Telaprevir Biology Medicine Antivirals		17 AprilAnalyst Stuart RobertsAssociate Analyst Tanushree Jain Add to Reading List Source URL: www.biotron.com.au Download Document from Source Website File Size: 1,02 MB Share Document on Facebook

	Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases DocID: 1qOAQ - View Document
	NIH Public Access Author Manuscript Haemophilia. Author manuscript; available in PMC 2015 September 01. NIH-PA Author Manuscript DocID: 1qx0K - View Document
	Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases DocID: 1qfUf - View Document
	Transplantologiya – 2015. – № 1. – P. 13–22. The use of telaprevir for the treatment of hepatitis C in patients undergoing liver transplantation (Literature review and clinical experience) M.Sh. Khubutiya1, V.E DocID: 1ngSx - View Document
	Microsoft PowerPoint - PHT SLA Spring 2012_ClinicalTrials_WEB.pptx DocID: 1msHW - View Document